Pharmacovigilance Market Size Worth USD 12.48 Billion by 2027

1
Pharmacovigilance Market Size Worth USD 12.48
Billion by 2027
www.emergenresearch.com
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global pharmacovigilance market is expected
to be worth USD 12.48 Billion by 2027, according
to a current analysis by Emergen Research. The
market for pharmacovigilance is experiencing
rapid growth attributed to a rise in application
for spontaneous reporting, electronic health
record (HER) mining, cohort event monitoring, and
intensified adverse drug reaction (ADR)
reporting, among others. The pharmacovigilance
primarily emphasizes on on ADR (adverse drug
reactions) and cases of drug toxicity. According
to the statistic released by WHO, about 5.0 of
hospitalized patients in the developed nations
are admitted into the hospital due to adverse
drug reactions, and 6.0 to 10 of in-patients
are anticipated to observe a severe adverse
reaction for the duration of hospitalization. A
rise in demand for outsourcing services by
players in the healthcare industry is anticipated
to boost the forecast period's pharmacovigilance
market growth. A spiraling inclination to
outsource eliminates the issues pertaining to
overhead costs and the pharmacovigilance
resources deployment. 
www.emergenresearch.com
6
Market Summary

• Some Key Highlights from the Report
• In December 2019, UCB and Accenture made an
  announcement about signing of a partnership
  agreement to build a safety solution on INTIENT
  pharmacovigilance, by Accenture, to accelerate
  patient safety case reports processing. The
  agreement is intended to help UCB in discovering
  the influence of existing treatments on patients
  safety and therefore managing the novel drugs
  risk in a better way.
• Spontaneous reporting is a crucial type in
  pharmacovigilance by providing information from
  real clinical settings in the course of a drugs
  life. Physicians and many other healthcare
  specialists contribute immensely to improving
  public health by supposed adverse drug reactions
  reporting.
• Several firms support in-house reporting
  management to healthcare authorities, as in-house
  reporting is possibly the major contact entity
  for any kind of in and out deliberation.
• To receive a free sample of the report, visit _at_
  https//www.emergenresearch.com/request-sample/81

www.emergen research.com
7
Market Summary
Emergen Research has segmented the global
pharmacovigilance on the basis of type, service
provider, clinical trial phase, end-users, and
region Type Outlook (Revenue, USD Million
2017-2027) Spontaneous Reporting Intensified
Adverse Drug Reaction (ADR) Reporting Targeted
Spontaneous Reporting Cohort Event
Monitoring Electronic Health Record (HER)
Mining Service Provider Outlook (Revenue, USD
Million 2017-2027) In-House Contract
Outsourcing Request a discount on the report _at_
https//www.emergenresearch.com/request-discount/8
1
8
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
LATEST PUBLICATIONS
Latest published reports from the Healthcare
Sector by Emergen Research Clinical Decision
Support Systems (CDSS) Market_at_ https//www.emergen
research.com/industry-report/clinical-decision-sup
port-systems-cdss-market Cancer Immunotherapy
Market_at_ https//www.emergenresearch.com/industry-r
eport/cancer-immunotherapy-market Blockchain in
Healthcare Market_at_ https//www.emergenresearch.com
/industry-report/blockchain-in-healthcare-market
Biologics Market_at_ https//www.emergenresearch.com/
industry-report/biologics-market Alternative
Proteins Market_at_ https//www.emergenresearch.com/i
ndustry-report/alternative-proteins-market  
www.emergenresearch.com
11
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
12
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]